-+ 0.00%
-+ 0.00%
-+ 0.00%

Baoji Pharmaceutical-B (02659) plans to implement a full circulation plan for H shares

Zhitongcaijing·12/30/2025 09:17:02
Listen to the news

Zhitong Finance App News, Baoji Pharmaceutical-B (02659) issued an announcement. On December 30, 2025, the company submitted filing materials to the China Securities Regulatory Commission on the proposed implementation of full circulation of H shares to convert a total of 63.1163 million unlisted shares of the company into the company's H shares (accounting for about 19.36% of the total number of shares issued by the company on the date of this announcement).

After obtaining all relevant approvals (including filing notices from the China Securities Regulatory Commission and approval from the Stock Exchange) and complying with all applicable laws, regulations and rules, these unlisted shares will be converted to H shares, and the company will apply for approval to list and trade such H shares on the main board of the Stock Exchange. According to the company's articles of association, there is no need to hold a separate shareholders' meeting to approve the conversion and listing.